论文部分内容阅读
目的:对疏血通联合依达拉奉治疗脑梗死急性期疗效分析。方法:选取2013年10月-2014年10月东兴市人民医院收治的脑梗死急性期患者100例,作为本次研究对象,按照随机抽取的方式分为观察组和对照组各50例。对照组给予西医常规治疗,观察组在西医常规治疗上给予疏血通联合依达拉奉治疗。1个疗程后观察两组的治疗效果。结果:观察组总有效率为96.00%,对照组总有效率为80.00%,组间比较,差异有统计学意义(P<0.05);观察组神经功能缺损评分要高于对照组,差异有统计学意义(P<0.05)。结论:疏血通联合依达拉奉治疗急性期脑梗死能够有效改善神经功能缺损,提高治疗效果。
Objective: To analyze the curative effect of Shuxuetong combined with edaravone in acute stage of cerebral infarction. Methods: A total of 100 patients with acute cerebral infarction who were admitted to Dongxing People’s Hospital from October 2013 to October 2014 were selected as the study subjects and divided into observation group and control group according to the method of random sampling. The control group was given routine treatment of Western medicine, and the observation group was treated with Shuxuetong combined with edaravone on the conventional treatment of Western medicine. After a course of treatment to observe the treatment effect of both groups. Results: The total effective rate was 96.00% in the observation group and 80.00% in the control group. The difference between the two groups was statistically significant (P <0.05). The score of neurological deficit in the observation group was higher than that of the control group Significance (P <0.05). Conclusion: Combination of Shuxuetong and edaravone in the treatment of acute cerebral infarction can effectively improve neurological deficits and improve the therapeutic effect.